» Articles » PMID: 11073174

Physician-assisted Suicide in the United States: the Underlying Factors in Technology, Health Care and Palliative Medicine--Part One

Overview
Publisher Springer
Specialty Medical Ethics
Date 2000 Nov 10
PMID 11073174
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In an age of rapid advances in life-prolonging treatment, patients and caregivers are increasingly facing tensions in making end-of-life decisions. An examination of the history of health care in the United States reveals technological, economic, and medical factors that have contributed to the problems of terminal care and consequently to the movement of assisted suicide. The movement has its roots in at least two fundamental perceptions and expectations. In the age of technological medicine energized by the profit motive, dying comes at a high price in suffering and in personal economic loss. The failure to provide affordable resources for terminal care is the result of the marketplace in health care. The medical profession has been painfully slow in responding to the challenges of terminal care, mainly because of the pressures of the marketplace and lack of adequate training. This has occurred at a time of rapid advances in life-sustaining treatment and of expanding public awareness of personal rights under the law. Overly aggressive treatment in the final stages of terminal illness has enhanced anxieties over a painfully prolonged and expensive dying. These factors have promoted the movement to assisted suicide. In the U.S. debate of the issues, ethicists tend to argue abstractly without examining adequately the context of terminal care that is the health care system. It is a system in dire need of a reform that will remove it from the marketplace.

Citing Articles

Analysis of suicide risk in adult US patients with squamous cell carcinoma: a retrospective study based on the Surveillance, Epidemiology and End Results database.

Yu H, Tao S, She W, Liu M, Wu Y, Lyu J BMJ Open. 2022; 12(9):e061913.

PMID: 36109023 PMC: 9478846. DOI: 10.1136/bmjopen-2022-061913.


Risk factors associated with suicide among leukemia patients: A Surveillance, Epidemiology, and End Results analysis.

Yu H, Cai K, Huang Y, Lyu J Cancer Med. 2020; 9(23):9006-9017.

PMID: 33022890 PMC: 7724501. DOI: 10.1002/cam4.3502.


Primum non nocere: could the health care system contribute to suffering? In-depth study from the perspective of terminally ill cancer patients.

Daneault S, Lussier V, Mongeau S, Hudon E, Paille P, Dion D Can Fam Physician. 2007; 52(12):1574-5.

PMID: 17279239 PMC: 1783759.

References
1.
Christakis N, Asch D . Biases in how physicians choose to withdraw life support. Lancet. 1993; 342(8872):642-6. DOI: 10.1016/0140-6736(93)91759-f. View

2.
Cleeland C, GONIN R, Hatfield A, Edmonson J, Blum R, Stewart J . Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994; 330(9):592-6. DOI: 10.1056/NEJM199403033300902. View

3.
Stephenson J . Experts say AIDS pain 'dramatically undertreated'. JAMA. 1996; 276(17):1369-70. View

4.
Ahronheim J, Morrison R, Baskin S, Morris J, Meier D . Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Arch Intern Med. 1996; 156(18):2094-100. View

5.
Emanuel E . Cost savings at the end of life. What do the data show?. JAMA. 1996; 275(24):1907-14. View